Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Short term Debt (2010 - 2026)

Bioxytran (BIXT) posted Short term Debt of $355598.0 for Q1 2026, down 10.13% sequentially from $395668.0 in Q4 2025, and up 640.83% YoY from $48000.0 in Q1 2025.

Bioxytran (BIXT) Short term Debt (2010 - 2026) Analysis & Trends

Bioxytran has reported Short term Debt for 15 years, with the latest figure at $355598.0 in Q1 2026.

  • Quarterly Short term Debt rose 640.83% year-over-year to $355598.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $355598.0 (up 640.83% YoY) and the FY2025 annual result came in at $395668.0, up 64.12% from the prior year.
  • Short term Debt slipped to $355598.0 in Q1 2026 per BIXT's latest filing, from $395668.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $541405.0 in Q3 2025 and troughed at $25000.0 in Q3 2023.
  • A 4-year average of $169263.6 and a median of $70974.0 in 2024 frame the typical range for Short term Debt.
  • The widest YoY moves for Short term Debt: up 1324.75% in 2025, down 34.34% in 2025.
  • Over 4 years, Short term Debt stood at $25000.0 in 2023, then soared by 864.31% to $241078.0 in 2024, then soared by 64.12% to $395668.0 in 2025, then declined by 10.13% to $355598.0 in 2026.
  • According to Business Quant data, Short term Debt over the past three periods registered $355598.0, $395668.0, and $541405.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Bioxytran 2.47 Mn 2.22 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 355,598.00
Dec 31, 2025 395,668.00
Sep 30, 2025 541,405.00
Jun 30, 2025 48,070.00
Mar 31, 2025 48,000.00
Dec 31, 2024 241,078.00
Sep 30, 2024 38,000.00
Jun 30, 2024 70,974.00
Mar 31, 2024 73,107.00
Dec 31, 2023 25,000.00
Sep 30, 2023 25,000.00
Mar 31, 2021 420,750.00
Sep 30, 2020 8,115.00
Jun 30, 2018 25,000.00
Mar 31, 2018 5,000.00
Dec 31, 2017 5,000.00
Sep 30, 2017 5,000.00
Jun 30, 2017 5,000.00
Mar 31, 2017 25,000.00
Dec 31, 2016 25,000.00